Outdoors Notebook: U.S. visitor bookings to Ontario decline, industry survey shows
The survey, conducted in May, provides a snapshot of industry sentiment as the province heads into peak travel season — and offers early indicators of where the sector is headed — according to the TIAO news release.
Among the highlights:
* Domestic demand leads: Ontario remains the top source market, with most operators noting booking pace that is either the same or better compared to this time last year.
* U.S. visitation slows: 32% of operators report lower bookings from U.S. visitors for summer 2025 vs. last year.
* Shorter booking windows: Last-minute booking behavior is on the rise due to cautious consumers.
* Cost pressures intensify: 37% of operators cite cost increases due to U.S. tariffs and supply issues; 28% regularly source goods from the U.S.
On the web:
tiaontario.ca
.
onX Fish Midwest, a digital mapping and discovery tool for anglers has expanded into North Dakota, according to an item published on the Fishing Wire online news platform.
"North Dakota was an obvious next choice for us," Joel Nelson, onX Fish marketing manager, told the Fishing Wire. "Given the state's year-round angling options for several key species in a host of remote environments, our app helps anglers both understand what's in the lakes and the best ways to get there."
To mark the expansion, onX and the North Dakota Game and Fish Department (NDGF) have teamed up to give new customers a free three-month onX Fish Midwest membership for anglers who buy their fishing licenses through the Game and Fish Department's online licensing platform. After making their purchase, anglers will receive a message in their NDGF online account with a free access code to unlock their onX Fish Midwest trial.
onX Fish Midwest debuted in Minnesota in early 2024. In addition to Minnesota and North Dakota, the app is currently available in Wisconsin and Michigan, and will continue to expand across the region and nationally, the company said.
ST. PAUL — Wildlife researchers with the Minnesota Department of Natural Resources are getting ready to begin the final year of a five-year fawn study, fitting newborn white-tailed deer with GPS-tracking collars in southwest Minnesota.
With the aid of a contracted drone pilot, the research team locates fawns that are usually one to five days old in their natural habitat. From there, a team of three to four people navigates to the fawn on foot to locate and capture the fawn.
Once captured, researchers measure length, weight and overall health before deploying an ear tag and slipping on an expandable GPS collar that grows with the fawn.
The whole capture process is typically completed in about four minutes to minimize stress on the fawn. The team has collared about 100 fawns each year and plans to do so again this year.
The GPS collars assist in providing information about fawn survival rates, primary causes of fawn mortality, types of habitats they prefer and long-distance movements.
The collars are designed to break away from the deer around 18 months of age, at which time the collar provides an exact geolocation for retrieval. While in use, the collar's attached transmitter alerts the team when a fawn remains stationary for multiple hours straight — indicating the fawn may have died. The alert is helpful for the team to quickly locate the fawn and find clues in case of the animal's death.
For updates on this year's effort, follow the
Minnesota Fish and Wildlife Facebook
page.
ST. PAUL — Targeted culling is a management action the Minnesota DNR uses to slow the spread of chronic wasting disease where it is known to exist. In a news release, the DNR said it does not cull deer across a broad area; all efforts are focused within 2 miles of recent positives within the past couple years. All culling is conducted with landowner permission. Nearly 30% of all CWD-positive deer found in Minnesota since 2010 were removed through culling.
Targeted culling efforts in the south metro (Deer Permit Area 605) were conducted in February. Efforts also took place during March in Crow Wing County (DPA 604) and near Grand Rapids (DPA 679). In total, these culling efforts within three areas combined resulted in 201 samples, with one result (from the Grand Rapids area) indicating a positive CWD detection.
All deer culled are processed by a licensed meat processor and the venison is stored until test results are received. Deer that receive a "not detected" test result are given back to participating landowners or donated to food banks for distribution to local food shelves. All deer that test positive are brought to the University of Minnesota Diagnostic Laboratory for disposal in an alkaline digestor.
The DNR website
at
mndnr.gov
has more info about targeted culling and CWD test results.
ST. PAUL — Does typically give birth to fawns from mid-May to mid-June, which allows fawns time to grow and prepare for the winter. However, people may encounter fawns later in the summer and wonder what caused that.
In a news release, the DNR said a doe cycles into estrus every 28 days, and it has been observed in captivity for a doe to go into estrus up to six times a year. The majority of does become pregnant during their first estrus cycle, but if you have ever observed a fawn with spots that was clearly born later in the summer, it is likely a result of a late-bred doe. Some reasons for this include uneven buck-to-doe ratios, a doe having a miscarriage and cycling back into estrus, or fawn females becoming of age and size to be bred. The latter is likely the most common reason in areas with good nutrition.
ST. PAUL — The DNR is seeking people with a range of perspectives and experiences, including local fishing guides, local anglers, anglers from across Minnesota, local businesses and local resorts, and water-based businesses, to serve on two fisheries input groups: one for Lake Winnibigoshish and the other for Rainy Lake.
The groups work closely with the DNR to provide input on fisheries management activities on these lakes, including any activities that are authorized, licensed, permitted or otherwise regulated or managed by the state. Minnesota residents can apply online through Tuesday, June 24, to serve on the fisheries input groups for Lake Winnibigoshish or Rainy Lake.
The DNR supports the groups by supplying information relevant to their discussions, including standard fish population assessments, creel (angler) surveys, status of invasive species or other available information requested by the groups.
Detailed committee and application information for each group is available on the
Rainy Lake page
at
mndnr.gov/rainylake
and the
Lake Winnibigoshish page
at
mndnr.gov/bigwinnie
.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Oil Steadies Near Two-Month Low as IEA Warns of Record Glut
(Bloomberg) -- Oil steadied near a two-month low after the International Energy Agency said the market is on track for record oversupply next year. Brent traded below $66 a barrel, after closing at its lowest since June 5 on Wednesday, while West Texas Intermediate was around $63. The US-Canadian Road Safety Gap Is Getting Wider Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets Gloomy predictions from both the IEA and the US government this week come as supplies from both within and outside OPEC+ are expected to rise into the fourth quarter. Brent's nearest timespread — a guage of market health — is trading at its weakest level since May. Against that backdrop, traders are monitoring the lead-up to Friday's summit between the US and Russian presidents, given that it may result in an easing or tightening of Washington's sanctions on the OPEC+ member. Donald Trump warned he would impose 'very severe consequences' if Vladimir Putin didn't agree to a ceasefire, following a call with European leaders. Oil has lost more than 10% this year as the Organization of the Petroleum Exporting Countries and its partners complete the reversal of output curbs started in 2023, though price moves have been limited in recent days as trading activity eases over the summer months in the northern hemisphere. 'We estimate Brent prices could land in the low $60s if there is progress toward a US-Russia deal,' Citigroup analysts including Anthony Yuen wrote, adding that the most likely outcome of the meeting will 'favor the downside.' --With assistance from Charlie Zhu and Sarah Chen. Americans Are Getting Priced Out of Homeownership at Record Rates Dubai's Housing Boom Is Stoking Fears of Another Crash Why It's Actually a Good Time to Buy a House, According to a Zillow Economist Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan The Electric Pickup Truck Boom Turned Into a Big Bust ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
3 hours ago
- Forbes
How Trade Wars And Interest Rates Are Reshaping Canadian Investments
Elie Nour, CEO at Nour Private Wealth (NPW). In 2025, Canadian investors face unprecedented challenges and opportunities. While many continue to rely on investment strategies that served them well over the past decade, the convergence of global trade tensions and monetary policy shifts demands a fundamental reconsideration of how wealth is built and preserved. The investment environment you navigated just 18 months ago bears little resemblance to today's reality. The New Economic Chessboard Trade wars between major economies intensified in 2024 and into this year, creating ripple effects that directly impact Canadian portfolios across global markets. These geopolitical tensions represent structural changes to investment fundamentals that many advisors have yet to incorporate fully into their recommendations. Consider the case of a typical Toronto-based investor with exposure to multinational corporations. The second-order effects of tariff escalations have transformed the profit potential of these formerly reliable performers, with supply chain restructuring costs possibly eliminating much of their margin advantages. What once represented portfolio stability may now introduce unexpected volatility. At the same time, the Bank of Canada's rate cut cycle has created a deceptive environment for fixed-income investors. The initial euphoria of rate reductions masks significant challenges in achieving meaningful returns through traditional bond allocations. The Canadian Advantage: Overlooked Sectors The current economic realignment presents uniquely Canadian opportunities that remain underappreciated by mainstream investment analysis. Resource sovereignty is a critical economic factor in 2025. Canadian companies positioned at the intersection of essential minerals, clean energy infrastructure and advanced manufacturing are experiencing structural tailwinds that transcend typical market cycles. Take, for example, a forestry and metals conglomerate based in British Columbia. By pivoting toward materials essential for the energy transition, this formerly cyclical business has secured preferential status in North American supply chains, fundamentally altering its risk-return profile. Interest Rate Illusions The Bank of Canada's monetary policy requires sophisticated interpretation, with experts mixed about the likelihood of another rate cut in the near future. While declining rates typically signal opportunity in specific sectors, the current environment demands nuance in execution. Many wealth management strategies naively assume that rate cuts automatically benefit all equities equally. This superficial analysis overlooks how the causes of rate adjustments impact different business models asymmetrically. Companies with strong pricing power and low capital intensity demonstrate particular resilience in this environment. One often-overlooked consideration is that the impact of rate cuts on financial institutions varies dramatically based on their loan book composition and duration structure. Regional Canadian banks with appropriate positioning present compelling value propositions that larger financial institutions cannot match. Portfolio Construction For Canadian Realities Conventional portfolio construction fails to account for the specific challenges facing Canadian investors this year. The traditional 60/40 stock/bond allocation requires significant modification to thrive in current conditions. Strategic defensive positioning must be balanced with targeted exposure to sectors benefiting from emerging economic patterns. This is not about radical portfolio overhauls but rather thoughtful recalibration based on forward-looking analysis. What does this mean practically? Consider a professional couple in their 40s with a seven-figure portfolio. Their optimal allocation now might include increased exposure to Canadian mid-cap companies with strong domestic supply chains, complemented by select positions in businesses benefiting from nearshoring trends. The fixed income portion requires particular attention, with duration management becoming increasingly crucial. Duration management involves selecting bonds with suitable maturities to balance risk and income. Bonds with shorter durations tend to reduce interest rate sensitivity and maintain reinvestment flexibility. Bonds with longer durations, meanwhile, tend to favor environments where rates are expected to drop—especially if these bonds feature a high yield. Wealth Preservation Through Strategic Adaptation The current environment rewards strategic adaptability rather than reactive adjustments. High-net-worth Canadians should consider three specific adjustments to their investment approach: 1. Reassess geographic allocations, with particular attention to domestic opportunities that are insulated from trade disruptions. The conventional wisdom of broad international diversification requires refinement in an era of economic fragmentation. 2. Implement sector rotation strategies that capitalize on the transition from interest rate sensitivity to trade resilience as the dominant market factor. Sector rotation involves shifting investments between sectors based on economic cycles. This might mean reducing exposure to defensive sectors such as healthcare and consumer staples and increasing exposure to sectors that thrive in periods of expansion and growth, such as technology and consumer discretionary. This shift is particularly relevant for the Canadian energy and materials sectors. 3. Introduce alternative income streams beyond traditional fixed income. Private credit opportunities with appropriate risk parameters can provide yield advantages that public markets cannot currently match. The Total Wealth Picture Sophisticated wealth management extends beyond portfolio construction to encompass a broader range of financial planning considerations. In the current environment, the tax implications of investment decisions are particularly important. Canadian investors face a distinctive set of tax considerations that international investment advice often overlooks. Considerations include tax implications for domestic (and foreign) dividends, interest income and capital gains (and losses); the incorporation of registered accounts to optimize overall tax efficiency; and the strategic use of federal and provincial tax deductions and credits. Coordinating registered and non-registered accounts becomes increasingly important as the characteristics of interest and dividend income evolve in response to changing monetary policy. Positioning For Resilience And Opportunity The convergence of trade tensions and shifts in monetary policy creates a challenging environment for Canadian investors. Yet within this complexity lie significant opportunities for those who recognize evolving economic patterns. The key to positive investment outcomes in such times lies in applying proven investment principles with greater sophistication and awareness of current realities. Canadian investors who adapt their strategies to incorporate these insights position themselves to capitalize on emerging opportunities in this transformed investment landscape. The information provided here is not investment, tax or financial advice. You should consult with a licensed professional for advice concerning your specific situation. Forbes Finance Council is an invitation-only organization for executives in successful accounting, financial planning and wealth management firms. Do I qualify?
Business Wire
3 hours ago
- Business Wire
WELL Health Reports Record Revenue, Adjusted EBITDA, and Adjusted Net Profit in Q2-2025, Upgrades Guidance, and Delivers First-Ever Quarter With More Than 1 Million Patient Visits in Canada
VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the ' Company ' or ' WELL '), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2025. Hamed Shahbazi, Chairman and CEO of WELL commented, 'I am very proud of our performance this quarter as it reflects a very significant milestone in our history with best-ever performances across most of our key financial metrics. We delivered record performances across Revenue, Adjusted EBITDA, Adjusted Net Income, and patient visits. Furthermore, we would have reported best-ever Free Cash Flow Available to Shareholders had we not had elevated cash taxes and capital expenditures due to new investments made in our Canadian clinics, executive health and longevity health portfolios, which have historically delivered excellent returns on capital invested (ROIC). Importantly, we also delivered $17M in IFRS net profit for the quarter demonstrating our ability to deliver on all key adjusted and non-adjusted metrics. I'm also very pleased to commemorate that we delivered more than 1 million patient visits in Canada during the quarter for the first time ever reflecting 38% YoY growth; approximately a third of which came from organic growth. It's important to remember the significance of each of those visits and how vital it can be to a person's health and wellness. This awareness, along with our growing scale and relevance in the healthcare ecosystem, is top of mind for us. We think about it every day as we are committed to making the investments that are designed to help healthcare providers deliver the best care and patient outcomes possible. One positive by-product of our investments is the growing productivity of our providers. The average provider at WELL grew its number of patient visits by 22%. While there are many contributors to this improvement, we believe improved tooling and technology to be one of those key reasons.' Mr. Shahbazi further added, "We are also very pleased to report our first quarter with the inclusion of HEALWELL AI, a company that we helped launch and incubate almost two years ago and in which we took a majority voting control position this past April. Yesterday HEALWELL reported record financial performance along with its first profitable quarter on an Adjusted EBITDA basis and signalled its intent to become a pure-play SaaS and Services company now that it has achieved significant scale in delivering data science and healthcare software expertise to large enterprise customers in 11 countries globally. In parallel, we continue to evaluate strategic alternatives for our U.S. assets to simplify our business and sharpen our focus on our core Canadian operations. Across the WELL ecosystem, our teams are focused on driving sustainable, profitable growth and delivering meaningful impact through technology, innovation, and operational excellence.' Eva Fong, WELL's Chief Financial Officer, commented, 'Our second quarter results demonstrate the strength of our operating model and disciplined approach to capital allocation. Year to date, we have completed fourteen transactions and are pleased to report fifteen signed LOIs representing approximately $134 million in revenues. Our high-quality pipeline of acquisition opportunities mostly includes targets across Canadian Clinics and WELLSTAR. Also, notably our WELLSTAR platform delivered another strong 'Rule of 40' performance with strong organic revenue growth and healthy Adjusted EBITDA margins, while executing on its M&A pipeline. WELLSTAR's goal is to exceed $100 million in revenues next year with continued strong margins and growth metrics. Overall, we remain committed to improving margin profile and operating leverage across the organization, while evaluating strategic opportunities to streamline and optimize our portfolio. With a strong balance sheet and increasing cash generation, we are well-positioned to support long-term growth and return value to shareholders.' Second Quarter 2025 Financial Highlights: WELL achieved record quarterly revenue of $356.7 million in Q2-2025, an increase of 57% compared to revenue of $227.3 million generated in Q2-2024. This growth was mainly driven by organic growth, acquisitions that have occurred over the last twelve months and the addition of $40.5 million of revenue in Q2-2025 from the inclusion of HEALWELL, as per IFRS reporting requirements following the company's execution of a call option to acquire voting shares of HEALWELL on April 1, 2025, relating to our majority voting position with HEALWELL. Excluding the impact of 'CM Deferrals', revenue would have reached $347.0 million, representing a 53% increase compared to the previous year. Adjusted Gross Profit (1) was $158.7 million in Q2-2025, an increase of 73% compared to Adjusted Gross Profit of $91.5 million in Q2-2024. Adjusted Gross Margin (1) percentage was 44.5% during Q2-2025 compared to Adjusted Gross Margin percentage of 40.3% in Q2-2024. The increase in Adjusted Gross Margin percentage was primarily driven by revenue mix and the addition of higher margin HEALWELL revenue, while being offset by the addition of lower margin Provider Staffing revenue from the acquisition of Harmony in January 2025. Adjusted EBITDA (1) was $49.7 million in Q2-2025, an increase of 231% compared to Adjusted EBITDA of $15.0 million in Q2-2024. Excluding the impact of CM Deferrals, Adjusted EBITDA would have reached $40.0 million, representing a 166% increase compared to the previous year. Adjusted EBITDA Attributable to WELL shareholders was $37.5 million in Q2-2025, an increase of 215% compared to Adjusted EBITDA Attributable to WELL shareholders of $11.9 million in Q2-2024. Adjusted Net Income (1) was $25.8 million, or $0.10 per share in Q2-2025, compared to Adjusted Net Income of $4.1 million, or $0.02 per share in Q2-2024. Free Cash Flow Available to Shareholders (or FCFA2S) was $11.7 million in Q2-2025 an increase of 34% compared to FCFA2S of $8.7 million in Q2-2024. Note that FCFA2S was impacted by elevated cash taxes and capital expenditures which were focused on investments in upgrading our clinical portfolio. Segmented Revenue: Canadian Patient Services revenue was $114.5 million in Q2-2025, an increase of 49% compared to $76.7 million in Q2-2024. U.S. Patient Services revenue was $184.8 million in Q2-2025, an increase of 38% compared to $133.7 million in Q2-2024. WELLSTAR, the Company's pure-play SaaS technology subsidiary, achieved revenue of $15.2 million in Q2-2025, an increase of 49% compared to $10.2 million in Q2-2024. WELLSTAR's growth was driven by healthy organic growth and acquisitions. Second Quarter 2025 Patient Visit Metrics: WELL achieved a total of 1.7 million patient visits in Q2-2025, an increase of 21% compared to 1.4 million patient visits in Q2-2024. Canadian Patient Services visits increased 38% while US Patient Services visits decreased 1%, on a year-over-year basis. Notably, the Company achieved over 1 million patient visits across its Canadian operations, a new quarterly milestone. Growth in patient visits over the past year was primarily driven by acquisitions as well as double-digit organic growth, including the clinic absorption program. In addition, WELL achieved over 2.7 million Care Interactions (2) in Q2-2025, representing approximately 10.8 million patient interactions on an annualized run-rate basis. Second Quarter 2025 Business Highlights: On April 1, 2025, the Company and the pre-HEALWELL founders amended the terms of the conditional call option held by the Company to acquire up to 30.8 million Class A Subordinate Voting Shares of HEALWELL at $0.125 per share and 30.8 million Class B Multiple Voting shares of HEALWELL at $0.0001 per share such that it became exercisable, and the Company exercised the call option to acquire such shares for total consideration of $3.9 million. On April 1, 2025, the release conditions were satisfied related to the Company's January 21, 2025, subscription for HEALWELL shares and the Company received 0.5 million Class A voting shares and 0.25 million share purchase warrants with each warrant exercisable into one Class A Subordinate Voting share at $2.50 per share for a period of 36 months in accordance with the terms of the subscription agreement. As of April 1, 2025, the Company held 97.2 million Class A Subordinate Shares and 30.8 million Class B Multiple Voting shares of HEALWELL, representing approximately 37% of the economic interest and approximately 69% of the voting rights in HEALWELL on a non-diluted basis. As a result, the Company obtained control of HEALWELL under IFRS, and accordingly, began to consolidate the financial results of HEALWELL as a subsidiary of the Company effective April 1, 2025. On May 6, 2025, the Company announced the rebranding of its cybersecurity division as CYBERWELL and the appointment of Jeffrey Engle as CEO. CYBERWELL consolidates four firms: Source44, SeekIntoo, Cycura, and Proack Security into a unified cybersecurity company. The division will focus on recurring revenue, acquisitions, and international expansion. WELL noted plans for CYBERWELL to potentially be spun out in the future and serve as a key growth engine. On May 7, 2025, WELLSTAR announced the launch of Nexus AI, a new AI-powered clinical documentation solution available across Canada. The product is initially focused on AI scribing and will expand through partnerships across the WELL ecosystem. Nexus AI is supported by government funding for up to 10,000 providers through Canada Health Infoway's AI Scribe pilot program. On May 28, 2025, the Company announced that subsidiaries of HEALWELL and WELLSTAR, Intrahealth, Pentavere, and OceanMD, were selected as recipients of Canada Health Infoway's 2025 Vendor Innovation Program. The program supports the development and implementation of real-world interoperability solutions aligned with national digital health priorities. The selected projects aim to enhance data quality, care coordination, and access to standardized health information across Canada, with deployments planned in five provinces. Three of the eight recipients are affiliated with the WELL and HEALWELL group. On June 24, 2025, the Company announced the availability of over 45,000 new primary care patient openings across its clinic network in Ontario, Alberta, and Manitoba. The expansion is enabled by investments in physician recruitment, including the onboarding of internationally trained medical graduates, and the implementation of digital infrastructure powered by WELLSTAR Technologies. The Company's National Patient Registration system, supported by OceanMD's eForms, online booking, and automated triage tools, is streamlining access and enabling clinics to accelerate the creation of new patient panels. Events Subsequent to June 30, 2025: On July 8, 2025, the Company announced the completion of two clinic acquisitions in British Columbia, effective July 1, 2025. The acquired clinics include a personalized health clinic in Vancouver and a multidisciplinary clinic in Burnaby, expanding the Company's presence in preventative health and specialty care. On July 8, 2025, the Company announced an expansion and extension of its senior secured credit facility, led by Royal Bank of Canada, increasing total capacity to approximately $200 million and extending the maturity to 2027. The revised facility converts the accordion feature into a revolving credit line, enhancing the Company's financial flexibility to support continued growth. On July 15, 2025, the Company announced that its majority-owned subsidiary, WELLSTAR Technologies Corp., executed three letters of intent for acquisitions expected to contribute approximately $15 million in ARR, $16 million in annual revenue, and over $5 million in Adjusted EBITDA on a run-rate basis. The targets deliver high-margin SaaS solutions that expand WELLSTAR's clinician enablement platform and support its strategy of disciplined, accretive growth. On July 16, 2025 HEALWELL acquired the remaining 49% of Pentavere Research Group Inc. ('Pentavere'), by exercising a call option that it had previously negotiated at the time of its original acquisition of a majority interest in Pentavere in 2023. Pursuant to the call option, HEALWELL acquired all of the remaining issued and outstanding shares of Pentavere for an aggregate purchase price of $13,978 which was satisfied with the issuance of 10,161,562 HEALWELL Class A Subordinate Voting Shares. With 100% ownership of Pentavere, HEALWELL intends to deepen integration between its AI businesses and accelerate commercialization of AI products across healthcare offerings. Outlook: WELL intends to continue its focus on maintaining strong performance, while strategically enhancing operations in the pursuit of organic growth and profitability. WELL is expecting its momentum to continue in the second half of the year across its key business units. WELL's objective is to invest in and achieve significant growth while effectively managing its costs and delivering cash flow to shareholders. Management is pleased to reaffirm its 2025 annual guidance for revenue to be between $1.40 billion to $1.45 billion, representing 52% to 58% annual growth compared to 2024. Excluding the impact of the CM Deferrals, the Company's annual revenue guidance would be between $1.35 billion to $1.40 billion. This annual revenue guidance only includes announced acquisitions; however, WELL expects to be in the upper half of this guidance range with the inclusion of planned acquisitions in the second half of the year. Furthermore, management is pleased to increase its guidance for annual Adjusted EBITDA to be in the upper half of its previously provided guidance of $190 million to $210 million. Excluding the impact of CM Deferrals, the Company is similarly improving its guidance for annual Adjusted EBITDA to be in the upper half of its previously provided guidance of $140 million to $160 million. This improvement of the Company's annual Adjusted EBITDA guidance only includes announced acquisitions. WELL continues to allocate capital thoughtfully in order to activate both organic and inorganic growth. The Company expects to continue to fund its acquisitions from its own cash flow as well as planned divestitures ensuring compounding gains over time on a per share basis. The Company also continues to focus most of its M&A and capital allocation activity in Canada where it is experiencing its strongest returns. Conference Call: WELL will release its Second Quarter 2025 financial results for the period ended June 30, 2025, on Thursday, August 14, 2025. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm ET (10:00 am PT). Please use the following dial-in numbers: 1-800-717-1738 (Toll Free) or 1-289-514-5100 (International). The conference call will also be simultaneously webcast and can be accessed at the following audience URL: Selected Unaudited Financial Highlights: Please see SEDAR for complete copies of the Company's condensed interim consolidated financial statements and interim MD&A for the quarter ended June 30, 2025. Footnotes: Non-GAAP financial measures and ratios. In addition to results reported in accordance with IFRS, the Company uses certain non-GAAP financial measures as supplemental indicators of its financial and operating performance. These non-GAAP financial measures include Adjusted Net Income, Adjusted Net Income Per Share, Adjusted EBITDA, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted Free Cash Flow. The Company believes these supplementary financial measures reflect the Company's ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in its business. Adjusted Net Income and Adjusted Net Income per Share The Company defines Adjusted Net Income as net income (loss), after excluding the effects of share-based payments, amortization of acquired intangible assets, time-based earnout expense, change in fair value of investments, change in fair value of derivative liability, non-controlling interests, and revenue precluded from recognition under IFRS 15 that relates to certain patient services revenue that the Company believes should be recognized as revenue based on its contractual relationships. Adjusted Net Income Per Share is Adjusted Net Income divided by weighted average number of shares outstanding. The Company believes that these non-GAAP financial measures provide useful information to analyze our results, enhance a reader's understanding of past financial performance and allow for greater understanding with respect to key metrics used by management in decision making. More specifically, the Company believes Adjusted Net Income is a financial metric that tracks the earning power of the business that is available to WELL shareholders. EBITDA and Adjusted EBITDA EBITDA and Adjusted EBITDA are non-GAAP measures. EBITDA represents net income (loss) before interest, taxes, depreciation, and amortization. The Company defines Adjusted EBITDA as EBITDA (i) less net rent expense on premise leases considered to be finance leases under IFRS and (ii) before transaction, restructuring, and integration costs, time-based earn-out expense, change in fair value of investments, change in fair value of derivative liability, share of loss of associates, foreign exchange gain/loss, and share-based payments, (iii) revenue precluded from recognition under IFRS 15 that relates to certain patient services revenue that the Company believes should be recognized as revenue based on its contractual relationships, and (iv) gains/losses that are not reflective of ongoing operating performance. The Company considers Adjusted EBITDA a financial metric that measures cash that the Company can use to fund working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. EBITDA and Adjusted EBITDA should not be considered alternatives to net income (loss), cash flow from operating activities or other measures of financial performance in accordance with IFRS. Adjusted Gross Profit and Adjusted Gross Margin The Company defines Adjusted Gross Profit as revenue less cost of sales (excluding depreciation and amortization) and Adjusted Gross Margin as adjusted gross profit as a percentage of revenue. Adjusted gross profit and adjusted gross margin should not be construed as an alternative for revenue or net income (loss) determined in accordance with IFRS. The Company does not present gross profit in its consolidated financial statements as it is a non-GAAP financial measure. The Company believes that adjusted gross profit and adjusted gross margin are meaningful metrics that are often used by readers to measure the Company's efficiency of selling its products and services. Adjusted Free Cash Flow The Company defines Adjusted Free Cash Flow Attributable to Shareholders as Adjusted EBITDA Attributable to Shareholders, less cash interest, less cash taxes and less capital expenditures. Adjusted Net income, Adjusted Net Income per Share, Adjusted EBITDA, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted Free Cash Flow are not recognized measures for financial statement presentation under IFRS and do not have standardized meanings. As such, these measures may not be comparable to similar measures presented by other companies and should be considered as supplements to, and not as substitutes for, or superior to, the corresponding measures calculated in accordance with IFRS. Total Care Interactions are defined as Total Patient Visits plus Technology Interactions plus Billed Provider Hours. WELL HEALTH TECHNOLOGIES CORP. Per: 'Hamed Shahbazi' Hamed Shahbazi Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp. WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 34,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 165 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about WELL, please visit: Forward-Looking Statements This news release may contain 'Forward-Looking Information' within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the Company's goals, strategies and growth plans, including expected acquisitions and divestitures Company and HEALWELL; expectations regarding continued revenue and EBITDA growth; the Company's expectations pertaining to annual guidance for annual revenue and Adjusted EBITDA; the expected benefits and synergies of completed acquisitions; capital allocation plans in the form of more acquisitions or share repurchases; expected patient visits; and the expected financial performance as well as information in the 'Outlook' section herein. Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as 'may', 'should', 'will', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations. Forward-Looking Information involve known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL 's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including: risks regarding the timing and amount of recognition or revenue and earnings; direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; that future results may vary from historical results; inability to obtain any requisite future financing on suitable terms; any inability to realize the expected benefits and synergies of acquisitions; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at including its most recent Annual Information Form and its Management, Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise. This news release contains future-oriented financial information and financial outlook information (collectively, 'FOFI') about estimated annual run-rate revenue and Adjusted EBITDA, all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraph. The actual financial results of WELL may vary from the amounts set out herein and such variation may be material. WELL and its management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, WELL undertakes no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about WELL's anticipated future business operations on an annual basis. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein. Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
